Agilent Technologies Cash Flow from Investing Activities 2010-2024 | A

Agilent Technologies annual/quarterly cash flow from investing activities history and growth rate from 2010 to 2024. Cash flow from investing activities can be defined as the total change in cash resulting from a companies investments
  • Agilent Technologies cash flow from investing activities for the quarter ending January 31, 2024 was $-0.095B, a 8.65% decline year-over-year.
  • Agilent Technologies cash flow from investing activities for the twelve months ending January 31, 2024 was $-0.856B, a 3.76% increase year-over-year.
  • Agilent Technologies annual cash flow from investing activities for 2023 was $-0.31B, a 8.28% decline from 2022.
  • Agilent Technologies annual cash flow from investing activities for 2022 was $-0.338B, a 54.87% decline from 2021.
  • Agilent Technologies annual cash flow from investing activities for 2021 was $-0.749B, a 409.52% increase from 2020.
Agilent Technologies Annual Cash Flow Investing
(Millions of US $)
2023 $-310
2022 $-338
2021 $-749
2020 $-147
2019 $-1,590
2018 $-705
2017 $-304
2016 $-238
2015 $-400
2014 $-230
2013 $-248
2012 $-2,366
2011 $1,294
2010 $-1,174
2009 $-14
Sector Industry Market Cap Revenue
Computer and Technology Electrical Test Equipment $45.318B $6.833B
Agilent Technologies, Inc. is an original equipment manufacturer of a broad-based portfolio of test and measurement products serving multiple end markets. Recently, the company has diversified into new end markets, namely industrial, chemical and electronics markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG).The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers' representatives, telesales and electronic commerce, as necessary.
Stock Name Country Market Cap PE Ratio
AMETEK (AME) United States $39.026B 25.82
Fortive (FTV) United States $27.155B 21.98
Teradyne (TER) United States $21.779B 48.27
Cognex (CGNX) United States $8.327B 83.64
Itron (ITRI) United States $5.029B 26.74